These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 27300512)

  • 21. Construction of a CXCL12-KDEL fusion gene to inhibit head and neck squamous cell carcinoma metastasis by intracellular sequestration of CXCR4.
    Zhang W; Wang X; Yue K; Liu S; Liu X
    Biomed Res Int; 2015; 2015():195828. PubMed ID: 25866764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Relationship between chemokine axis CXCL12-CXCR4 and epithelial ovarian cancer].
    Guo Q; Wu XH; Lü YP; Yang B; Xu F; Zhang SJ
    Zhonghua Yi Xue Za Zhi; 2013 Jun; 93(21):1677-80. PubMed ID: 24125682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The CXCL12-CXCR4 Signaling Axis Plays a Key Role in Cancer Metastasis and is a Potential Target for Developing Novel Therapeutics against Metastatic Cancer.
    Yang P; Hu Y; Zhou Q
    Curr Med Chem; 2020; 27(33):5543-5561. PubMed ID: 31724498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone morphogenetic protein 9 overexpression reduces osteosarcoma cell migration and invasion.
    Lv Z; Yang D; Li J; Hu M; Luo M; Zhan X; Song P; Liu C; Bai H; Li B; Yang Y; Chen Y; Shi Q; Weng Y
    Mol Cells; 2013 Aug; 36(2):119-26. PubMed ID: 23807047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis.
    Wang J; Loberg R; Taichman RS
    Cancer Metastasis Rev; 2006 Dec; 25(4):573-87. PubMed ID: 17165132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional expression of CXCR4 in somatotrophs: CXCL12 activates GH gene, GH production and secretion, and cellular proliferation.
    Lee Y; Kim JM; Lee EJ
    J Endocrinol; 2008 Nov; 199(2):191-9. PubMed ID: 18753332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of CXCR4/CXCL12 signaling axis by ursolic acid leads to suppression of metastasis in transgenic adenocarcinoma of mouse prostate model.
    Shanmugam MK; Manu KA; Ong TH; Ramachandran L; Surana R; Bist P; Lim LH; Kumar AP; Hui KM; Sethi G
    Int J Cancer; 2011 Oct; 129(7):1552-63. PubMed ID: 21480220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of signaling between human CXCR4 and zebrafish ligands by the small molecule IT1t impairs the formation of triple-negative breast cancer early metastases in a zebrafish xenograft model.
    Tulotta C; Stefanescu C; Beletkaia E; Bussmann J; Tarbashevich K; Schmidt T; Snaar-Jagalska BE
    Dis Model Mech; 2016 Feb; 9(2):141-53. PubMed ID: 26744352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ANGPTL2 increases bone metastasis of breast cancer cells through enhancing CXCR4 signaling.
    Masuda T; Endo M; Yamamoto Y; Odagiri H; Kadomatsu T; Nakamura T; Tanoue H; Ito H; Yugami M; Miyata K; Morinaga J; Horiguchi H; Motokawa I; Terada K; Morioka MS; Manabe I; Iwase H; Mizuta H; Oike Y
    Sci Rep; 2015 Mar; 5():9170. PubMed ID: 25773070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Correlations of chemokine CXCL12 and its receptor to tumor metastasis].
    Jiang YP; Wu XH
    Ai Zheng; 2007 Feb; 26(2):220-4. PubMed ID: 17298758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic silencing of CXCL12 increases the metastatic potential of mammary carcinoma cells.
    Wendt MK; Cooper AN; Dwinell MB
    Oncogene; 2008 Feb; 27(10):1461-71. PubMed ID: 17724466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis.
    Pan J; Mestas J; Burdick MD; Phillips RJ; Thomas GV; Reckamp K; Belperio JA; Strieter RM
    Mol Cancer; 2006 Nov; 5():56. PubMed ID: 17083723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stromal cell-derived factor-1α and macrophage migration-inhibitory factor induce metastatic behavior in CXCR4-expressing colon cancer cells.
    Shin HN; Moon HH; Ku JL
    Int J Mol Med; 2012 Dec; 30(6):1537-43. PubMed ID: 23023114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blockade of CXCL12/CXCR4 signaling inhibits intrahepatic cholangiocarcinoma progression and metastasis via inactivation of canonical Wnt pathway.
    Zhao S; Wang J; Qin C
    J Exp Clin Cancer Res; 2014 Dec; 33(1):103. PubMed ID: 25471741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastases.
    Gil M; Seshadri M; Komorowski MP; Abrams SI; Kozbor D
    Proc Natl Acad Sci U S A; 2013 Apr; 110(14):E1291-300. PubMed ID: 23509246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of the CXCR4/CXCL12 axis blocks the activation of the Wnt/β-catenin pathway in human colon cancer cells.
    Song ZY; Gao ZH; Chu JH; Han XZ; Qu XJ
    Biomed Pharmacother; 2015 Apr; 71():46-52. PubMed ID: 25960214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone marrow mesenchymal stem cells promote osteosarcoma cell proliferation and invasion.
    Yu FX; Hu WJ; He B; Zheng YH; Zhang QY; Chen L
    World J Surg Oncol; 2015 Feb; 13():52. PubMed ID: 25890096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elucidating a key component of cancer metastasis: CXCL12 (SDF-1α) binding to CXCR4.
    Tamamis P; Floudas CA
    J Chem Inf Model; 2014 Apr; 54(4):1174-88. PubMed ID: 24660779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stromal cell-derived factor-1/CXCR4 enhanced motility of human osteosarcoma cells involves MEK1/2, ERK and NF-kappaB-dependent pathways.
    Huang CY; Lee CY; Chen MY; Yang WH; Chen YH; Chang CH; Hsu HC; Fong YC; Tang CH
    J Cell Physiol; 2009 Oct; 221(1):204-12. PubMed ID: 19496172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteotropism of neuroendocrine tumors: role of the CXCL12/ CXCR4 pathway in promoting EMT in vitro.
    Cives M; Quaresmini D; Rizzo FM; Felici C; D'Oronzo S; Simone V; Silvestris F
    Oncotarget; 2017 Apr; 8(14):22534-22549. PubMed ID: 28186979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.